LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
Data about efficacy and safety of long-term therapy with acetylsalicylic acid in patients with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal complications of the treatment are discussed.
Saved in:
Main Author: | I. V. Zhirov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/971 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01) -
Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01) -
ACETYLSALICYLIC ACID IN RHEUMATOLOGY: NEW EVIDENCE
by: Yuri Vladimirovich Muravyev, et al.
Published: (2013-12-01) -
ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01) -
ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE?
by: S. A. Boldueva, et al.
Published: (2015-12-01)